A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans

Genes and Immunity

Volumn 12, Issue 2, 2011, Pages 67-77

  Rybicki, B A ^a   Levin, A M ^a   McKeigue, P ^b   Datta, I ^a   Gray Mcguire, C ^c   Colombo, M ^b   Reich, D ^d   Burke, R R ^a   Iannuzzi, M C ^e  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

African continental ancestry group; granuloma; lung diseases; polymorphism; single nucleotide

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CHROMOSOME 10P; CHROMOSOME 6P; CHROMOSOME 8P; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MARKER; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THORAX RADIOGRAPHY;

AFRICAN AMERICANS; CHROMOSOME MAPPING; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOIDOSIS;

EID: 79952282953     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.56     Document Type: Article

References (59)

1. ATS Board of Directors and by the ERS Executive Committee. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). Am J Respir Crit Care Med 1999; 160: 736-755.
2. Schurmann M, Lympany PA, Reichel P, Muller-Myhsok B, Wurm K, Schlaak M et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000; 162: 861-864.
3. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357-364.
4. Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A et al. BTNL2 gene variant and sarcoidosis. Thorax 2006; 61: 273-274.
5. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 2005; 77: 491-499. (Pubitemid 41192655)
6. Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 2007; 70: 219-227. (Pubitemid 47106649)
7. Rybicki BA, Hirst K, Iyengar SK, Barnard JG, Judson MA, Rose CS et al. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 115-122. (Pubitemid 41020016)
8. Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston RC, Baughman RP, Donohue JF et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005; 6: 509-518. (Pubitemid 43090509)
9. Rybicki BA, Sinha R, Iyengar S, Gray-McGuire C, Elston RC, Iannuzzi MC. Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes Immun 2007; 8: 379-386. (Pubitemid 47163101)
10. Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008; 40: 1103-1106.
11. Rybicki BA, Major M, Popovich JJ, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241.
12. Gundelfinger BF, Britten SA. Sarcoidosis in the United States Navy. Am Rev Respir Dis 1961; 84(suppl): 109-115.
13. Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol 1974; 99: 250-257.
14. Benatar SR. Sarcoidosis in South Africa. A comparative study inWhites, Blacks and Coloureds. S Afr Med J 1977; 52: 602-606. (Pubitemid 8224953)
15. Edmondstone WM, Wilson AG. Sarcoidosis in Caucasians, Blacks and Asians in London. Br J Dis Chest 1985; 79: 27-36. (Pubitemid 15162036)
16. Shriver MD, Parra EJ, Dios S, Bonilla C, Norton H, Jovel C et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 2003; 112: 387-399. (Pubitemid 36869067)
17. Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204-211. (Pubitemid 37351542)
18. Smith MW, Patterson N, Lautenberger JA, Truelove AL, McDonald GJ, Waliszewska A et al. A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 2004; 74: 1001-1013. (Pubitemid 38568970)
19. Tian C, Hinds DA, Shigeta R, Kittles R, Ballinger DG, Seldin MF. A genome-wide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet 2006; 79: 640-649. (Pubitemid 44452741)
20. Terwilliger JD, Weiss KM. Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr Opin Biotechnol 1998; 9: 578-594. (Pubitemid 28558488)
21. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A,Waliszewska A et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 2006; 103: 14068-14073. (Pubitemid 44452981)
22. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008; 40: 1175-1184.
23. Scherer ML, Nalls MA, Pawlikowska L, Ziv E, Mitchell GF, Huntsman S et al. Admixture mapping of ankle-arm index: identification of a candidate locus associated with peripheral arterial disease. J Med Genet 2009; 47: 1-7.
24. Elbein SC, Das SK, Hallman DM, Hanis CL, Hasstedt SJ. Genome-wide linkage and admixture mapping of type 2 diabetes in African American families from the American Diabetes Association GENNID (Genetics of NIDDM) Study Cohort. Diabetes 2009; 58: 268-274.
25. Basu A, Tang H, Arnett D, Gu CC, Mosley T, Kardia S et al. Admixture mapping of quantitative trait loci for BMI in African Americans: evidence for loci on chromosomes 3q, 5q, and 15q. Obesity (Silver Spring) 2009; 17: 1226-1231.
26. Cheng CY, Kao WH, Patterson N, Tandon A, Haiman CA, Harris TB et al. Admixture mapping of 15,280 African Americans identifies obesity susceptibility loci on chromosomes. 5. and X. PLoS Genet 2009; 5: e1000490.
27. Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet 2007; 80: 716-726. (Pubitemid 46564408)
28. Basu A, Tang H, Lewis CE, North K, Curb JD, Quertermous T et al. Admixture mapping of quantitative trait loci for blood lipids in African-Americans. Hum Mol Genet 2009; 18: 2091-2098.
29. Hoggart CJ, Shriver MD, Kittles RA, Clayton DG, McKeigue PM. Design and analysis of admixture mapping studies. Am J Hum Genet 2004; 74: 965-978. (Pubitemid 38568969)
30. Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR et al. Methods for high-density admixture mapping of disease genes. Am J Hum Genet 2004; 74: 979-1000. (Pubitemid 38578397)
31. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E. Results from a genomewide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001; 164: 840-846. (Pubitemid 32881922)
32. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007; 3: e58.
33. Onnie C, Fisher SA, King K, Mirza M, Roberts R, Forbes A et al. Sequence variation, linkage disequilibrium and association with Crohn's disease on chromosome 5q31. Genes Immun 2006; 7: 359-365. (Pubitemid 44111640)
34. Chang M, Li Y, Yan C, Callis-Duffin KP, Matsunami N, Garcia VE et al. Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun 2008; 9: 176-181. (Pubitemid 351351659)
35. Li Y, Chang M, Schrodi SJ, Callis-Duffin KP, Matsunami N, Civello D et al. The 5q31 variants associated with psoriasis and Crohn's disease are distinct. Hum Mol Genet 2008; 17: 2978-2985.
36. Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003; 73: 720-735. (Pubitemid 37271878)
37. Sato H, Grutters JC, Pantelidis P, Mizzon AN, Ahmad T, van Houte AJ et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 406-412.
38. Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 2003; 167: 1225-1231. (Pubitemid 36555094)
39. Voorter CE, Drent M, van den Berg-Loonen EM. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602- DRB1*150101. Hum Immunol 2005; 66: 826-835. (Pubitemid 41169773)
40. Cao K, Moormann AM, Lyke KE, Masaberg C, Sumba OP, Doumbo OK et al. Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 2004; 63: 293-325. (Pubitemid 38406692)
41. Lazarus R, Vercelli D, Palmer LJ, Klimecki WJ, Silverman EK, Richter B et al. Single nucleotide polymorphisms in innate immunity genes: abundant variation and potential role in complex human disease. Immunol Rev 2002; 190: 9-25. (Pubitemid 36071923)
42. Lind JM, Hutcheson-Dilks HB, Williams SM, Moore JH, Essex M, Ruiz-Pesini E et al. Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet 2007; 120: 713-722. (Pubitemid 44942855)
43. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998; 63: 1839-1851. (Pubitemid 30415746)
44. Foreman MG, Mannino DM, Kamugisha L, Westney GE. Hospitalization for patients with sarcoidosis: 1979-2000. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 124-129. (Pubitemid 47471831)
45. Burke RR, Stone CH, Havstad S, Rybicki BA. Racial differences in sarcoidosis granuloma density. Lung 2009; 187: 1-7.
46. Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet 1965; 29: 51-76.
47. Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J, Chase Jr GA et al. Familial risk ratio of sarcoidosis in African- American sibs and parents. Am J Epidemiol 2001; 153: 188-193. (Pubitemid 32060611)
48. Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164: 2085-2091. (Pubitemid 34020250)
49. McDougal KE, Fallin MD, Moller DR, Song Z, Cutler DJ, Steiner LL et al. Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Invest Dermatol 2009; 129: 1921-1926.
50. Fischer A, Valentonyte R, Nebel A, Nothnagel M, Muller- Quernheim J, Schurmann M et al. Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Lofgren's syndrome. J Mol Med 2008; 86: 553-561.
51. Furuya K, Yamaguchi E, Itoh A, Hizawa N, Ohnuma N, Kojima J et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 1996; 51: 777-780. (Pubitemid 26274076)
52. Kruit A, Ruven HJ, Grutters JC, Van Den Bosch JM. Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 195-203. (Pubitemid 41668356)
53. Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007; 28: 1-6. (Pubitemid 46274179)
54. Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997; 156: 1601-1605. (Pubitemid 27505531)
55. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696-702. (Pubitemid 38338921)
56. Johns CJ, Schonfeld SA, Scott PP, Zachary JB, MacGregor MI. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications. Ann N Y Acad Sci 1986; 465: 702-712. (Pubitemid 16006612)
57. Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, Till A et al. Genome-wide association analysis in sarcoidosis and Crohn's disease unravels a common susceptibility locus on 10p12. 2. Gastroenterology 2008; 135: 1207-1215.
58. ACCESS Group. Design of a case control etiologic study of sarcoidosis (ACCESS) ACCESS Research Group. J Clin Epidemiol 1999; 52: 1173-1186.
59. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007; 449: 851-861. (Pubitemid 47598626)